Financing Europe’s Next Act

As Europe emerges from the COVID pandemic, having been at the forefront of innovation that is paving the way out, it’s faced with the question of how to chart a path forward. Can Europe create a next act that sets it up to be as important to public health in the post-pandemic world as it was during the crisis?

This analysis examines the state of innovation leading up and into the pandemic, focusing on Europe’s innovative “money magnets” — a class of 86 companies drawing investor attention and poised to shape the next wave of European biotech. It asks two principal questions:...